Annual report
2385.TEDINET S100RWNQ
Period2022-07-01 → 2023-06-30
Filed2023-09-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥8.9bn | 2020-07-01 → 2021-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.6bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥726m | 2022-07-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥727m | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥920m | 2020-07-01 → 2021-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥878m | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥725m | 2022-07-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.3bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥452m | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥810m | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥562m | 2020-07-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥732m | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥553m | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥456m | 2022-07-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥817m | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥8.2bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥7.1bn | at 2021-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.4bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.3bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.2bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2021-06-30d | Cons. | Net assets |
| Net assets / equity | ¥5.8bn | at 2020-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥5.2bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.9bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2021-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2020-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.1bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥102m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥107m | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥830m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥469m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥160m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥245m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥25m | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥693m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥289m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥130m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥130m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥131m | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥103m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥52m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥17.27 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.95 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.49 | 2020-07-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.97 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.16 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥266.41 | at 2023-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥254.14 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥230.88 | at 2021-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥214.39 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥190.87 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 84.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.5% | at 2021-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.7% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.5% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.6% | 2022-07-01 → 2023-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.7% | 2020-07-01 → 2021-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.8% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 98 | at 2023-06-30 | Cons. | Number of employees |
| Employees | 100 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 104 | at 2021-06-30d | Cons. | Number of employees |
| Employees | 105 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 101 | at 2019-06-30d | Cons. | Number of employees |
| Revenue | ¥377m | 2022-07-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥439m | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥425m | 2020-07-01 → 2021-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥425m | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥303m | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥81m | 2022-07-01 → 2023-06-30 | Standalone | Operating income |
| Operating income | ¥134m | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Ordinary income | ¥87m | 2022-07-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥137m | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥132m | 2020-07-01 → 2021-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥116m | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥73m | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥87m | 2022-07-01 → 2023-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥137m | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Net income | ¥142m | 2022-07-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | ¥195m | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥288m | 2020-07-01 → 2021-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥155m | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥111m | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.3bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥4.5bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥4.2bn | at 2021-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.1bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.0bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥21m | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥196m | at 2022-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥4.3bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.3bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.2bn | at 2021-06-30d | Standalone | Net assets |
| Net assets / equity | ¥4.1bn | at 2020-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.0bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥5.44 | 2022-07-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.47 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.02 | 2020-07-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.91 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.26 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥5 | 2022-07-01 → 2023-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2020-07-01 → 2021-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥163.95 | at 2023-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥163.52 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥161.05 | at 2021-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥155.03 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥153.56 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 99.5% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.6% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.5% | at 2021-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.6% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.3% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.3% | 2022-07-01 → 2023-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.6% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2020-07-01 → 2021-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 26,158,200 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2021-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 7 | at 2023-06-30 | Standalone | Number of employees |
| Employees | 9 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 8 | at 2021-06-30d | Standalone | Number of employees |
| Employees | 8 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 7 | at 2019-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 92
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-07-01 → 2023-06-30 | ¥244,000 |
| Reconciling Itemsreconciling | depreciation | 2022-07-01 → 2023-06-30 | ¥217,000 |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-06-30 | −¥25m |
| Reconciling Itemsreconciling | revenue external | 2022-07-01 → 2023-06-30 | ¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment assets | at 2023-06-30 | ¥1.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-06-30 | −¥294m |
| Clinical Evidence Servicereportable segment | capex | 2022-07-01 → 2023-06-30 | ¥8m |
| Clinical Evidence Servicereportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥4m |
| Clinical Evidence Servicereportable segment | employees | at 2023-06-30 | 20 pure |
| Clinical Evidence Servicereportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥617m |
| Clinical Evidence Servicereportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥602m |
| Clinical Evidence Servicereportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥15m |
| Clinical Evidence Servicereportable segment | segment assets | at 2023-06-30 | ¥427m |
| Clinical Evidence Servicereportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥89m |
| Functional Cosmetic Retailingreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥29m |
| Functional Cosmetic Retailingreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥13m |
| Functional Cosmetic Retailingreportable segment | employees | at 2023-06-30 | 29 pure |
| Functional Cosmetic Retailingreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥3.9bn |
| Functional Cosmetic Retailingreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥3.9bn |
| Functional Cosmetic Retailingreportable segment | segment assets | at 2023-06-30 | ¥3.3bn |
| Functional Cosmetic Retailingreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥658m |
| Functional Food Retailingreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥3m |
| Functional Food Retailingreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥5m |
| Functional Food Retailingreportable segment | employees | at 2023-06-30 | 25 pure |
| Functional Food Retailingreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥2.5bn |
| Functional Food Retailingreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥2.5bn |
| Functional Food Retailingreportable segment | segment assets | at 2023-06-30 | ¥1.3bn |
| Functional Food Retailingreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥137m |
| Functional Material Developmentreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥1m |
| Functional Material Developmentreportable segment | employees | at 2023-06-30 | 9 pure |
| Functional Material Developmentreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥501m |
| Functional Material Developmentreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥490m |
| Functional Material Developmentreportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥11m |
| Functional Material Developmentreportable segment | segment assets | at 2023-06-30 | ¥1.4bn |
| Functional Material Developmentreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥43m |
| Health Care Support Servicereportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥935,000 |
| Health Care Support Servicereportable segment | employees | at 2023-06-30 | 8 pure |
| Health Care Support Servicereportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥553m |
| Health Care Support Servicereportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥553m |
| Health Care Support Servicereportable segment | segment assets | at 2023-06-30 | ¥315m |
| Health Care Support Servicereportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥93m |
| —segment total | capex | 2022-07-01 → 2023-06-30 | ¥39m |
| —segment total | depreciation | 2022-07-01 → 2023-06-30 | ¥25m |
| —segment total | revenue | 2022-07-01 → 2023-06-30 | ¥8.1bn |
| —segment total | revenue external | 2022-07-01 → 2023-06-30 | ¥8.1bn |
| —segment total | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥26m |
| —segment total | segment assets | at 2023-06-30 | ¥6.8bn |
| —segment total | segment profit | 2022-07-01 → 2023-06-30 | ¥1.0bn |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥237,000 |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-06-30 | −¥9m |
| Reconciling Itemsreconciling | revenue external | 2021-07-01 → 2022-06-30 | ¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-06-30 | −¥11m |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | ¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥304m |
| Clinical Evidence Servicereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥5m |
| Clinical Evidence Servicereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥2m |
| Clinical Evidence Servicereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥552m |
| Clinical Evidence Servicereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥552m |
| Clinical Evidence Servicereportable segment | segment assets | at 2022-06-30 | ¥453m |
| Clinical Evidence Servicereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥6m |
| Functional Cosmetic Retailingreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥5m |
| Functional Cosmetic Retailingreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥11m |
| Functional Cosmetic Retailingreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥5.0bn |
| Functional Cosmetic Retailingreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥5.0bn |
| Functional Cosmetic Retailingreportable segment | segment assets | at 2022-06-30 | ¥3.7bn |
| Functional Cosmetic Retailingreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥1.1bn |
| Functional Food Retailingreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥34m |
| Functional Food Retailingreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥3m |
| Functional Food Retailingreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥2.7bn |
| Functional Food Retailingreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥2.7bn |
| Functional Food Retailingreportable segment | segment assets | at 2022-06-30 | ¥1.3bn |
| Functional Food Retailingreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥200m |
| Functional Material Developmentreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥2m |
| Functional Material Developmentreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥569m |
| Functional Material Developmentreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥558m |
| Functional Material Developmentreportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥11m |
| Functional Material Developmentreportable segment | segment assets | at 2022-06-30 | ¥1.3bn |
| Functional Material Developmentreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥83m |
| Health Care Support Servicereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥709,000 |
| Health Care Support Servicereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥1m |
| Health Care Support Servicereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥549m |
| Health Care Support Servicereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥549m |
| Health Care Support Servicereportable segment | segment assets | at 2022-06-30 | ¥330m |
| Health Care Support Servicereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥117m |
| —segment total | capex | 2021-07-01 → 2022-06-30 | ¥45m |
| —segment total | depreciation | 2021-07-01 → 2022-06-30 | ¥20m |
| —segment total | revenue | 2021-07-01 → 2022-06-30 | ¥9.4bn |
| —segment total | revenue external | 2021-07-01 → 2022-06-30 | ¥9.3bn |
| —segment total | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥11m |
| —segment total | segment assets | at 2022-06-30 | ¥7.2bn |
| —segment total | segment profit | 2021-07-01 → 2022-06-30 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,234
| Item | Context | Value | Unit |
|---|---|---|---|
| Information for each of main customers (text) | Prior1YearDuration | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of corporate bonds (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of borrowings (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of asset retirement obligations (text) | CurrentYearDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding assets and liabilities incurred from transactions with affiliated entities (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding total amount of operating transactions from or to affiliated entities and total amount of non operating transactions from or to affiliated entities (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of property plant and equipment etc (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of provisions (text) | CurrentYearDuration | Text · Plus | |
| Components of major assets and liabilities (text) | CurrentYearDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Overview of operational procedures for shares (text) | FilingDateInstant | Text · Plus | |
| Information about parent company etc of reporting company (text) | FilingDateInstant | Text · Plus | |
| Other reference information (text) | FilingDateInstant | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |